In this study, we found that higher expression of CD38TILs had lower percentage and absolute counts of CD3+ and CD3+CD4+ T cells, which suggested that CD38TILs might affect CD3+ and CD3+CD4+ T cells to promote tumor growth and metastasis. Here, CD4 is linked to neoplasm.